Growth Metrics

Anavex Life Sciences (AVXL) EPS (Basic) (QoQ) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Anavex Life Sciences 266.20 Mn 134.45 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 45.45%
Sep 30, 2025 31.25%
Jun 30, 2025 -23.08%
Mar 31, 2025 7.14%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 -7.69%
Mar 31, 2024 -18.18%
Dec 31, 2023 15.38%
Sep 30, 2023 7.14%
Jun 30, 2023 17.65%
Mar 31, 2023 -2.19%
Dec 31, 2022 99.59%
Sep 30, 2022 -25,610.06%
Jun 30, 2022 -16.66%
Mar 31, 2022 2.22%
Dec 31, 2021 6.67%
Sep 30, 2021 -7.14%
Jun 30, 2021 -16.67%
Mar 31, 2021 0.00%
Dec 31, 2020 -20.00%
Sep 30, 2020 9.09%
Jun 30, 2020 8.33%
Mar 31, 2020 0.00%
Dec 31, 2019 -9.09%
Sep 30, 2019 15.38%
Jun 30, 2019 13.33%
Mar 31, 2019 0.00%
Dec 31, 2018 -15.38%
Sep 30, 2018 -116.67%
Jun 30, 2018 45.45%
Mar 31, 2018 -22.22%
Dec 31, 2017 57.14%
Sep 30, 2017 -425.00%
Jun 30, 2017 0.00%
Mar 31, 2017 50.00%
Dec 31, 2016 55.56%
Sep 30, 2016 -200.00%
Jun 30, 2016 0.00%
Mar 31, 2016 50.00%
Dec 31, 2015 42.86%
Sep 30, 2015 4.55%
Jun 30, 2015 -83.33%
Mar 31, 2015 -100.00%
Dec 31, 2014 93.88%
Sep 30, 2014 -3,166.67%
Jun 30, 2014 0.00%
Mar 31, 2014 -400.00%
Dec 31, 2013 110.00%
Sep 30, 2013 -900.00%